14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.76 $3.76 Friday, 27th May 2022 CHMA stock ended at $3.76. During the day the stock fluctuated 0% from a day low at $3.76 to a day high of $3.76.
90 days $3.76 $3.76
52 weeks $3.76 $4.93

Historical Chiasma prices

Date Open High Low Close Volume
Sep 17, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 16, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 15, 2021 $3.76 $3.76 $3.76 $3.76 147
Sep 14, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 13, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 10, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 09, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 08, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 07, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 03, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 02, 2021 $3.76 $3.76 $3.76 $3.76 0
Sep 01, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 31, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 30, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 27, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 26, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 25, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 24, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 23, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 20, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 19, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 18, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 17, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 16, 2021 $3.76 $3.76 $3.76 $3.76 0
Aug 13, 2021 $3.76 $3.76 $3.76 $3.76 0
Click to get the best stock tips daily for free!

About Chiasma

Chiasma Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massa... CHMA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT